ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
13. September 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Ophthalmologists Favor Genentech’s Vabysmo and Regeneron’s Eylea HD for Diabetic Macular Edema Treatment Despite Payer Constraints
24. Juni 2024 09:27 ET
|
Spherix Global Insights
EXTON, PA., June 20, 2024, June 24, 2024 (GLOBE NEWSWIRE) -- The treatment landscape for Diabetic Macular Edema (DME) continues to evolve, with innovative therapies and emerging data significantly...
Aeroflow Health Celebrates New Growth Milestones & Reshares its Commitment to Employee Well-Being
13. Juni 2024 08:57 ET
|
Aeroflow Health
Aeroflow now employs 830+ team members, rapidly expanding its workforce with hundreds of new roles that have contributed to the local economy.
Aeroflow Health Announces its Participation at America's Health Insurance Plans’ AHIP 2024 Flagship Conference in Las Vegas, Nevada
07. Juni 2024 08:45 ET
|
Aeroflow Health
Aeroflow Health will attend and participate in the AHIP 2024 conference to discuss how to bridge the gap in care for underserved patients.
Rate of Switching from Regeneron’s Eylea to Genentech’s Vabysmo Doubled Over Past Year for Diabetic Macular Edema
01. November 2023 14:55 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 01, 2023 (GLOBE NEWSWIRE) -- As U.S. ophthalmologists increasingly embrace a wider array of treatment options, the landscape of the diabetic macular edema (DME) market has...
Aeroflow Healthcare Celebrates Success in its Home State with the Passage of North Carolina’s Breast Pump Tax Exemption
01. November 2023 09:00 ET
|
Aeroflow Healthcare
Aeroflow Healthcare worked with state leaders Rep. Tricia Cotham and Senator Paul Newton to push this legislation forward.
U.S. Department of Energy, Sunvapor and Oberon Fuels Aim to Unlock Zero-Emission Renewable Fuel Production with Test of Novel Solar Steam & Battery Technology
13. Juni 2023 09:01 ET
|
Oberon Fuels
Demonstration project will replace natural gas with zero-emission solar energy for production of Oberon’s rDME® fuel SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Energy is...
DCC Energy and Oberon Fuels to Boost Renewable Dimethyl Ether Production to Reduce Emissions of European LPG Market
29. März 2023 07:00 ET
|
Oberon Fuels
SAN DIEGO and DUBLIN, Ireland, March 29, 2023 (GLOBE NEWSWIRE) -- DCC plc, the leading international sales, marketing and support services group, has partnered with Oberon Fuels, the leading...
ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
08. März 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye Research
13. Februar 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...